merck rsv - Search News

Order byBest matchMost fresh

News

RSV, Merck and FDA

· 3h · on MSN

Merck & Co (MRK) RSV Antibody for Infants Approved by US FDA

Merck & Co., Inc. (NYSE:MRK) is one of the best wide moat stocks to buy now. On June 9, Merck’s preventative antibody shot received authorization from the U.S. Food and Drug Administration (FDA). This shot shields infants up to the age of one from the respiratory syncytial virus during their first RSV period.

Continue reading

Clinical Trials Arena · 4h

Merck’s Enflonsia receives FDA approval for RSV prophylaxis

· 1d · on MSN

US FDA approves Merck's RSV antibody for infants

22hon MSN

Newly approved therapy could offer another option for protecting infants from RSV, a common infection that can be deadly

The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 ...

WCCB Charlotte4h

New therapy approved for RSV in kids

WASHINGTON – The Food and Drug Administration has approved a new monoclonal antibody to protect infants from RSV. The ...

Fierce Pharma2d

Feeling RSV heat from Merck, Sanofi lays out early supply plans for Beyfortus

One day before the potential FDA approval of a rival respiratory syncytial virus (RSV) monoclonal antibody from Merck & Co., ...

Pharmalittle: We’re reading about a Merck shot for RSV, a lawsuit over an Arkansas PBM law, and more

Merck won FDA approval for a shot that protects against RSV, the most common cause of hospitalization among infants ...

Sanofi starts shipping RSV drug early as rival nears market

Clesrovimab has been held up by MSD (known as Merck & Co in the US and Canada) as offering simpler dosing and better clinical ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results